What initial therapeutic intervention is most appropriate for a patient with syncope due to obstructive shock from hypertrophic cardiomyopathy?

Study for the Board Certified Cardiology Pharmacist Exam. Utilize flashcards and answer multiple-choice questions with detailed explanations. Prepare efficiently for your certification!

In the case of syncope due to obstructive shock from hypertrophic cardiomyopathy, initiating treatment with an intravenous fluid bolus is the most appropriate intervention. This choice is grounded in the understanding of how hypertrophic cardiomyopathy (HCM) affects hemodynamics.

In HCM, the left ventricular outflow tract can be narrowed, especially during periods of increased contractility or afterload. This narrowing can lead to reduced cardiac output and subsequent obstructive shock, resulting in inadequate perfusion and syncope. Administering an intravenous fluid bolus helps to augment circulating blood volume, improving preload and potentially alleviating the outflow obstruction. This can enhance cardiac output by stabilizing hemodynamics and increasing venous return, which is crucial in a state of obstructive shock.

The other options, while they may be beneficial in certain contexts, do not directly address the underlying issue of preload and blood volume in the setting of HCM and obstructive shock. Medications such as phenylephrine and norepinephrine are vasopressors that primarily increase systemic vascular resistance, which may worsen the left ventricular outflow obstruction. Dobutamine, while inotropic, primarily increases contractility, which can similarly lead to increased obstruction in the out

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy